Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Birgit Eiermann"'
Publikováno v:
PLoS ONE, Vol 14, Iss 8, p e0220685 (2019)
PurposeTo describe the occurrence of potential drug-drug interactions (DDIs) in prescribed drugs, dispensed to pediatric outpatients in Sweden.MethodsA cross sectional study was conducted based on data from a national register of prescribed drugs, di
Externí odkaz:
https://doaj.org/article/81867d62a8dc430f898e4d2586a32b41
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e69545 (2013)
PurposeTo investigate the extent to which clinicians avoid well-established drug-drug interactions that cause statin-induced myopathy. We hypothesised that clinicians would avoid combining erythromycin or verapamil/diltiazem respectively with atorvas
Externí odkaz:
https://doaj.org/article/3cfc5db8c1fa4e22beaab8f79163cde6
Background Discrepancies in medication lists are common and can contribute to drug-related problems. This study was performed before the implementation of the National Medication List in Sweden, an intervention expected to improve the accuracy of med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::808887e2e6388e738aef4a14b3f93bfb
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-502152
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-502152
Publikováno v:
Lakartidningen. 119
Skewed information about medicines in social media influence the healthcare-patient contact. Healthcare staff need situation adapted evidence that can be linked to patient data. For 20 years Sweden has provided praised Pharmacological Knowledge Bases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::042e277e77f7e736bdfc767e622fe085
https://pubmed.ncbi.nlm.nih.gov/36106743
https://pubmed.ncbi.nlm.nih.gov/36106743
Publikováno v:
Studies in health technology and informatics. 294
Adverse drug reactions (ADRs) for all drugs in Europe are described in the legally approved Summary of Product Characteristics (SmPC). An overview of all ADRs of the patients' drug list can support healthcare staff to link patient symptoms to possibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7c95800c6540150b29092704a954069
https://pubmed.ncbi.nlm.nih.gov/35612120
https://pubmed.ncbi.nlm.nih.gov/35612120
Adverse drug reactions (ADRs) for all drugs in Europe are described in the legally approved Summary of Product Characteristics (SmPC). An overview of all ADRs of the patients’ drug list can support healthcare staff to link patient symptoms to possi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff839903a42e3613ced123e522c12c7c
https://doi.org/10.3233/shti220499
https://doi.org/10.3233/shti220499
Publikováno v:
Basicclinical pharmacologytoxicologyREFERENCES. 128(4)
Adverse drug reactions (ADRs) for all drugs in Europe are described in the legally approved Summary of Product Characteristics (SmPC). An overview of all ADRs of the patients' drug list can support healthcare staff to link patient symptoms to possibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2544cfe7605b271ebac8722d2d549dea
https://pubmed.ncbi.nlm.nih.gov/33523597
https://pubmed.ncbi.nlm.nih.gov/33523597
Autor:
Thomas M. Polasek, Birgit Eiermann, Brahim Achour, Lawrence J. Lesko, Adam S. Darwich, Youssef Daali, Jean-Luc Reny, Daniel F. B. Wright, Andrew J. McLachlan, Jack Cook, Kayode Ogungbenro, Amin Rostami-Hodjegan, Jeffrey K Aronson
Publikováno v:
Annual Review of Pharmacology and Toxicology, Vol. 61 (2021) pp. 225-245
Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in which the characteristics of each patient are considered as opposed to applying a one-size-fits-all alternative. This review prov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a8b173f69f191c3fb615e15cb0ef30
https://archive-ouverte.unige.ch/unige:149708
https://archive-ouverte.unige.ch/unige:149708
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 122:512-516
Drug-drug interactions are increasingly common, as patients are getting older and the number of drugs per patient is increasing. In this study, we investigated to which extent potential drug-drug interactions originated from single or multiple prescr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0745433c237d4f799fca9067c952f2a9
https://doi.org/10.1111/bcpt.12939
https://doi.org/10.1111/bcpt.12939
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 8, p e0220685 (2019)
PLoS ONE, Vol 14, Iss 8, p e0220685 (2019)
PurposeTo describe the occurrence of potential drug-drug interactions (DDIs) in prescribed drugs, dispensed to pediatric outpatients in Sweden.MethodsA cross sectional study was conducted based on data from a national register of prescribed drugs, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3998c59533ebb5c129c6a2a6e00acfad
http://europepmc.org/articles/PMC6681954
http://europepmc.org/articles/PMC6681954